BAIT

BLM10

YFL006W, S000007437, YFL007W
Proteasome activator; binds the core proteasome (CP) and stimulates proteasome-mediated protein degradation by inducing gate opening; required for sequestering CP into proteasome storage granule (PSG) during quiescent phase and for nuclear import of CP in proliferating cells; required for resistance to bleomycin, may be involved in protecting against oxidative damage; similar to mammalian PA200
Saccharomyces cerevisiae (S288c)
PREY

RPN4

SON1, UFD5, stress-regulated transcription factor RPN4, L000001984, YDL020C
Transcription factor that stimulates expression of proteasome genes; Rpn4p levels are in turn regulated by the 26S proteasome in a negative feedback control mechanism; RPN4 is transcriptionally regulated by various stress responses; relative distribution to the nucleus increases upon DNA replication stress
Saccharomyces cerevisiae (S288c)

Synthetic Lethality

A genetic interaction is inferred when mutations or deletions in separate genes, each of which alone causes a minimal phenotype, result in lethality when combined in the same cell under a given condition.

Publication

Blm10 promotes proteasomal substrate turnover by an active gating mechanism.

Dange T, Smith D, Noy T, Rommel PC, Jurzitza L, Legendre A, Finley D, Goldberg AL, Schmidt M

For optimal proteolytic function the central core of the proteasome (CP or 20S) has to associate with activators. Here we investigate the impact of the yeast activator Blm10 on proteasomal peptide and protein degradation. We find enhanced degradation of peptide substrates in the presence of Blm10 and demonstrate that Blm10 has the capacity to accelerate proteasomal turnover of the unstructured ... [more]

Unknown Oct. 24, 2011; 0(0); [Pubmed: 22025621]

Throughput

  • Low Throughput

Ontology Terms

  • phenotype: inviable (APO:0000112)

Related interactions

InteractionExperimental Evidence CodeDatasetThroughputScoreCurated ByNotes
RPN4 BLM10
Dosage Growth Defect
Dosage Growth Defect

A genetic interaction is inferred when over expression or increased dosage of one gene causes a growth defect in a strain that is mutated or deleted for another gene.

Low-BioGRID
3565068
RPN4 BLM10
Negative Genetic
Negative Genetic

Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a more severe fitness defect or lethality under a given condition. This term is reserved for high or low throughput studies with scores.

High-0.1817BioGRID
364737
RPN4 BLM10
Negative Genetic
Negative Genetic

Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a more severe fitness defect or lethality under a given condition. This term is reserved for high or low throughput studies with scores.

High-0.175BioGRID
2088813
BLM10 RPN4
Synthetic Growth Defect
Synthetic Growth Defect

A genetic interaction is inferred when mutations in separate genes, each of which alone causes a minimal phenotype, result in a significant growth defect under a given condition when combined in the same cell.

Low-BioGRID
163902

Curated By

  • BioGRID